Coronavirus-two infection among adults: A scoping review of literature published in 2023-24
- PMID: 40621515
- PMCID: PMC12223744
- DOI: 10.12669/pjms.41.6.12201
Coronavirus-two infection among adults: A scoping review of literature published in 2023-24
Abstract
Objective: To identify and synthesize evidence on Coronavirus-two infection (SARS-CoV-2) among adults diagnosed by polymerase chain reaction.
Methods: The protocol was registered on Open Science Forum (doi: 10.17605/OSF.IO/2837X). Three bibliographic databases (Medline, SCOPUS, and Web of Science) were searched from July 2024 to December 2024. Peer-reviewed, quantitative studies with participants aged 18 and over were eligible to enlist potential risk factors of SARS-CoV-2 infection confirmed by Polymerase Chain Reaction PCR). The evidence was summarized as illustrations and tabulations with risk factors grouped into various categories. EndNote 20 was used for deduplications and organization of the literature.
Results: Of 28,688 unique entries searched, 299 were shortlisted and 32 full-text manuscripts selected from 17 countries. There were two (6.2%) manuscripts based on real-time surveillance of at-risk populations. A total of 42 individual risk factors were examined in the evidence.
Conclusion: Low socioeconomic status and occupation were consistent risk factors of SARS-CoV-2 infection, with minimal representation from low- and middle-income countries in the evidence body. Future research should prioritize standardized methods and inclusion of underrepresented regions to enhance global applicability and inform targeted public health interventions.
Keywords: COVID-19; Low socioeconomic status; Pandemics; SARS-CoV-2; Self care.
Copyright: © Pakistan Journal of Medical Sciences.
Conflict of interest statement
Conflicts of interest: None.
Figures
Similar articles
-
Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD015397. doi: 10.1002/14651858.CD015397.pub2. Cochrane Database Syst Rev. 2024. PMID: 39665337
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
-
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2023 Nov 30;11:CD015395. doi: 10.1002/14651858.CD015395.pub3. PMID: 36126225 Free PMC article. Updated.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Measures implemented in the school setting to contain the COVID-19 pandemic.Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 May 2;5:CD015029. doi: 10.1002/14651858.CD015029.pub2. PMID: 35037252 Free PMC article. Updated.
References
-
- Razieh C, Shabnam S, Dambha-Miller H, Morris EJA, Yates T, Chudasama Y, et al. Socioeconomic inequalities in risk of infection with SARS-CoV-2 delta and omicron variants in the UK, 2020-22:analysis of the longitudinal COVID-19 Infection Survey. BMJ Med. 2024;3(1):9. doi:10.1136/bmjmed-2023-000624.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous